Chapter 15
Pharmacotherapy of Depression and Anxiety Disorders
Depresja: Przegląd
Depression is a common mental illness that manifests as major depression, persistent depressive disorder, and bipolar I and II disorders.
It can be ...
Leki przeciwdepresyjne: Przegląd
Antidepressant drugs alleviate symptoms of depression by enhancing neurotransmission in the brain.
These agents are classified based on their chemical ...
Leki przeciwdepresyjne: Trójpierścieniowe, SSRI i SNRI
Tricyclic antidepressants, or TCAs, are first-generation antidepressants.
They block serotonin and norepinephrine reuptake transporters while inhibiting ...
Leki przeciwdepresyjne: Inhibitory MAO i inne środki
Monoamine oxidase inhibitors, or MAOIs, inhibit monoamine oxidase, increasing neurotransmitter levels.
Atypical antidepressants encompass drugs with ...
Choroba Parkinsona: Przegląd
Neurodegenerative disorders are progressive conditions characterized by the irreversible loss of neurons in specific brain regions.
The primary ...
Choroba Parkinsona: Leczenie
Parkinson's Disease or PD is a neurodegenerative disorder characterized by an imbalance between cholinergic and reduced dopaminergic neurons.
The ...
Choroba Alzheimera: Przegląd
Alzheimer's disease, or AD, is a neurodegenerative disorder primarily affecting older adults, causing impaired memory and cognitive decline through ...
Choroba Alzheimera: Leczenie
The goal of Alzheimer's disease or AD pharmacotherapy is to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms, ...
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone